Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2005

Open Access 01-12-2005 | Research

Estimating a preference-based index for a menopause specific health quality of life questionnaire

Authors: John E Brazier, Jennifer Roberts, Maria Platts, York F Zoellner

Published in: Health and Quality of Life Outcomes | Issue 1/2005

Login to get access

Abstract

Background

The aim of the study was to develop a menopause-specific, preference-based health-related quality-of-life (HRQoL) index reflecting both menopausal symptoms and potential side-effects of Hormone Replacement Therapy (HRT).

Methods

The study had three phases: the development of a health state classification, a prospective valuation survey and the estimation of a model to interpolate HRQoL indices for all remaining health states as defined by the classification. A menopausal health state classification was developed with seven dimensions: hot flushes, aching joints/muscles, anxious/frightened feelings, breast tenderness, bleeding, vaginal dryness and undesirable androgenic signs. Each dimension contains between three and five levels and defines a total of 6,075 health states. A sample of 96 health states was selected for the valuation survey. These states were valued by a sample of 229 women aged 45 to 60, randomly selected from 6 general practice lists in Sheffield, UK. Respondents were asked to complete a time trade-off (TTO) task for nine health states, resulting in an average of 16.5 values for each health state.

Results

Mean health states valued range from 0.48 to 0.98 (where 1.0 is full health and zero is for states regarded as equivalent to death). Symptoms, as described by the classification system, can be rank-ordered in terms of their impact (from high to low) on menopausal HRQoL as follows: aching joints and muscles, bleeding, breast tenderness, anxious or frightened feelings, vaginal dryness, androgenic signs. Hot flushes did not significantly contribute to model fit. The preferred model produced a mean absolute error of 0.053, but suffered from bias at both ends of the scale.

Conclusion

This article presents an attempt to directly value a condition specific health state classification. The overall fit was disappointing, but the results demonstrate that menopausal symptoms are perceived by patients to have a significant impact on utility. The overall effect is modest compared to the more generic health state descriptions such as the EQ-5D. The resultant algorithm generates a preference-based index that can be used economic evaluation and that reflects the impact of this condition.
Appendix
Available only for authorised users
Literature
1.
go back to reference National Institute for Clinical Excellence: NICE Guide to the Methods of Technology Appraisal. NICE, London; 2004. National Institute for Clinical Excellence: NICE Guide to the Methods of Technology Appraisal. NICE, London; 2004.
2.
go back to reference Commonwealth Department of Health, Housing and Community Service In Guidelines for the pharmaceutical industry on the submission to the pharmaceutical benefits advisory committee. Canberra: Australian Government Publishing Service; 1992. Commonwealth Department of Health, Housing and Community Service In Guidelines for the pharmaceutical industry on the submission to the pharmaceutical benefits advisory committee. Canberra: Australian Government Publishing Service; 1992.
3.
go back to reference Ministry of Health (Ontario) In Ontario guidelines for the economic evaluation of pharmaceutical products. Toronto: Ministry of Health; 1994. Ministry of Health (Ontario) In Ontario guidelines for the economic evaluation of pharmaceutical products. Toronto: Ministry of Health; 1994.
4.
go back to reference Brazier J, Deverill M, Green C, Harper R, Booth A: A review of the use of health status measures in economic evaluation. Health Technol Assess 1999,3(i–iv):1–164. Brazier J, Deverill M, Green C, Harper R, Booth A: A review of the use of health status measures in economic evaluation. Health Technol Assess 1999,3(i–iv):1–164.
5.
go back to reference Tosteson ANA, Gabriel SE, Kneeland TS, Moncur MM, Manganiello PD, Schiff I, Ettinger B, Melton LJ: Has the impact of hormone replacement therapy on health-related quality of life been undervalued? J Womens Health Gend Based Med 2000, 9: 110–130. 10.1089/152460900318614CrossRef Tosteson ANA, Gabriel SE, Kneeland TS, Moncur MM, Manganiello PD, Schiff I, Ettinger B, Melton LJ: Has the impact of hormone replacement therapy on health-related quality of life been undervalued? J Womens Health Gend Based Med 2000, 9: 110–130. 10.1089/152460900318614CrossRef
6.
go back to reference Zoellner YF, Oliver P, Brazier JE, Alt J, Schaefer M: Reliability and validity of a newly developed menopause-specific quality-of-life questionnaire, the QualiPause Inventory (QPI). Qual Life Res 2001, 10: 260. Zoellner YF, Oliver P, Brazier JE, Alt J, Schaefer M: Reliability and validity of a newly developed menopause-specific quality-of-life questionnaire, the QualiPause Inventory (QPI). Qual Life Res 2001, 10: 260.
7.
go back to reference Brazier JE, Kolotkin RL, Crosby RD, Williams GR: Estimating a preference-based index from the Impact of Weight on Quality of Life Instrument (IWQOL-Lite) from the SF-6D. Value Health 2004, 7: 490–498. 10.1111/j.1524-4733.2004.74012.xPubMedCrossRef Brazier JE, Kolotkin RL, Crosby RD, Williams GR: Estimating a preference-based index from the Impact of Weight on Quality of Life Instrument (IWQOL-Lite) from the SF-6D. Value Health 2004, 7: 490–498. 10.1111/j.1524-4733.2004.74012.xPubMedCrossRef
8.
go back to reference Tsuchyia A, Brazier J, McColl E, Parkin D: Deriving preference-based condition-specific instruments: converting AQLQ into EQ-5D indices. Sheffield Health Economics Group Discussion Paper 02/01, School of Health and Related Research, University of Sheffield 2002. Tsuchyia A, Brazier J, McColl E, Parkin D: Deriving preference-based condition-specific instruments: converting AQLQ into EQ-5D indices. Sheffield Health Economics Group Discussion Paper 02/01, School of Health and Related Research, University of Sheffield 2002.
9.
go back to reference Dixon S, McEwan P, Currie CJ: Estimating the health utility of treatment in adults with growth hormone deficiency. J Outcomes Res 2003, 7: 1–12. Dixon S, McEwan P, Currie CJ: Estimating the health utility of treatment in adults with growth hormone deficiency. J Outcomes Res 2003, 7: 1–12.
10.
go back to reference Brazier JE, Dixon S: Condition specific measures in economic appraisal. Health Econ 1995, 4: 255–264.PubMedCrossRef Brazier JE, Dixon S: Condition specific measures in economic appraisal. Health Econ 1995, 4: 255–264.PubMedCrossRef
11.
go back to reference Revicki DA, Leidy NK, Brennan-Diemer F, Thompson C, Togias A: Development and preliminary validation of the multiattribute Rhinitis Symptom Utility Index. Qual Life Res 1998, 7: 693–702. 10.1023/A:1008860113818PubMedCrossRef Revicki DA, Leidy NK, Brennan-Diemer F, Thompson C, Togias A: Development and preliminary validation of the multiattribute Rhinitis Symptom Utility Index. Qual Life Res 1998, 7: 693–702. 10.1023/A:1008860113818PubMedCrossRef
12.
go back to reference Stolk EA, Busschbach JJ: Validity and feasibility of the use of condition-specific outcome measures in economic evaluation. Qual Life Res 2003, 12: 363–371. 10.1023/A:1023453405252PubMedCrossRef Stolk EA, Busschbach JJ: Validity and feasibility of the use of condition-specific outcome measures in economic evaluation. Qual Life Res 2003, 12: 363–371. 10.1023/A:1023453405252PubMedCrossRef
13.
go back to reference Revicki DA, Leidy NK, Brennan-Diemer F, Sorensen S, Togias A: Integrating patient preferences into health outcomes assessment: the multiattribute Asthma Symptom Utility Index. Chest 1998, 114: 998–1007.PubMedCrossRef Revicki DA, Leidy NK, Brennan-Diemer F, Sorensen S, Togias A: Integrating patient preferences into health outcomes assessment: the multiattribute Asthma Symptom Utility Index. Chest 1998, 114: 998–1007.PubMedCrossRef
14.
go back to reference Kok ET, McDonnell J, Stolk EA, Stoevelaar HJ, Busschbach JJ, Triumph Research Group; Pan-European Expert Panel: The valuation of the International Prostate Symptom Score (IPSS) for the use in economic evaluations. Eur Urol 2002, 42: 491–497. 10.1016/S0302-2838(02)00403-7PubMedCrossRef Kok ET, McDonnell J, Stolk EA, Stoevelaar HJ, Busschbach JJ, Triumph Research Group; Pan-European Expert Panel: The valuation of the International Prostate Symptom Score (IPSS) for the use in economic evaluations. Eur Urol 2002, 42: 491–497. 10.1016/S0302-2838(02)00403-7PubMedCrossRef
15.
go back to reference Zoellner YF, Oliver P, Brazier JE, Schaefer M: Development of the 'QualiPause toolkit' to assess quality of life in climacteric and postmenopausal women. Gynecol Endocrinol 2001,15(Suppl 5):56. Zoellner YF, Oliver P, Brazier JE, Schaefer M: Development of the 'QualiPause toolkit' to assess quality of life in climacteric and postmenopausal women. Gynecol Endocrinol 2001,15(Suppl 5):56.
16.
go back to reference Brazier J, Roberts J, Deverill M: The estimation a preference-based single index measure for health from the SF-36. J Health Econ 2002, 21: 271–292. 10.1016/S0167-6296(01)00130-8PubMedCrossRef Brazier J, Roberts J, Deverill M: The estimation a preference-based single index measure for health from the SF-36. J Health Econ 2002, 21: 271–292. 10.1016/S0167-6296(01)00130-8PubMedCrossRef
17.
go back to reference Gudex C: Time trade-off user manual: Props and self-completion Methods. Centre for health Economics, University of York, York; 1994. Gudex C: Time trade-off user manual: Props and self-completion Methods. Centre for health Economics, University of York, York; 1994.
18.
go back to reference Dolan P: Modelling valuation for Euroqol health states. Med Care 1997, 35: 1095–1108. 10.1097/00005650-199711000-00002PubMedCrossRef Dolan P: Modelling valuation for Euroqol health states. Med Care 1997, 35: 1095–1108. 10.1097/00005650-199711000-00002PubMedCrossRef
19.
go back to reference Abdalla M, Russell I: Tariffs for the Euroqol health states based on modelling individual VAS and TTO data of the York Survey. MVH Group Final Report on the Modelling of Valuation Tariffs Centre for Health Economics, University of York 1995. Abdalla M, Russell I: Tariffs for the Euroqol health states based on modelling individual VAS and TTO data of the York Survey. MVH Group Final Report on the Modelling of Valuation Tariffs Centre for Health Economics, University of York 1995.
20.
go back to reference Drummond MF, O'Brien B, Stoddart GL, Torrance GW: Methods for the economic evaluation of health care programmes. Oxford: Oxford Medical Publications; 1997. Drummond MF, O'Brien B, Stoddart GL, Torrance GW: Methods for the economic evaluation of health care programmes. Oxford: Oxford Medical Publications; 1997.
21.
go back to reference Llewellyn-Thomas H, Sutherland HJ, Tibshirani R, Ciampi A, Till JE, Boyd NF: The measurement of patients' values in medicine. Med Decis Making 1982, 2: 449–462.PubMedCrossRef Llewellyn-Thomas H, Sutherland HJ, Tibshirani R, Ciampi A, Till JE, Boyd NF: The measurement of patients' values in medicine. Med Decis Making 1982, 2: 449–462.PubMedCrossRef
22.
go back to reference Rutten-Van-Mölken M: Costs and effects of pharmacotherapy in asthma and COPD. In PhD Thesis. Universitaire Press Maastricht Datawyse Maastricht; 1994. Rutten-Van-Mölken M: Costs and effects of pharmacotherapy in asthma and COPD. In PhD Thesis. Universitaire Press Maastricht Datawyse Maastricht; 1994.
23.
go back to reference Dowie J: Decision validity should determine whether generic or condition-specific HRQOL measure is used in health care decisions. Health Econ 2002, 11: 1–8.PubMedCrossRef Dowie J: Decision validity should determine whether generic or condition-specific HRQOL measure is used in health care decisions. Health Econ 2002, 11: 1–8.PubMedCrossRef
Metadata
Title
Estimating a preference-based index for a menopause specific health quality of life questionnaire
Authors
John E Brazier
Jennifer Roberts
Maria Platts
York F Zoellner
Publication date
01-12-2005
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2005
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/1477-7525-3-13

Other articles of this Issue 1/2005

Health and Quality of Life Outcomes 1/2005 Go to the issue